Though it is unclear whether the virus became pathogenic before or after the jump from animals to humans, genomic features point to a natural source for the COVID-19 coronavirus.
The institute will use the funds to continue combining genomic and digital technologies with bioinformatics to advance medical research and clinical care.
The prospective analysis suggests that the approach could help clinicians identify patients at risk of a stroke who could benefit from anticoagulant treatment.
Scripps researchers estimate that there could have been as many as 30 different introductions of the Zika virus into Florida, Medscape Medical News says.
Investigators plan to expand the program nationwide, with the hope that it can help guide care for living family members and further understanding of causal diseases.
The Washington Post reports that the White House chief of staff has asked the US Food and Drug Administration to justify the stricter standards it is seeking for a coronavirus vaccine.
